Global BCG Vaccine for Tuberculosis (TB) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global BCG Vaccine for Tuberculosis (TB) market size was valued at US$ 82.7 million in 2024 and is forecast to a readjusted size of USD 101 million by 2031 with a CAGR of 3.0% during review period.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
This report is a detailed and comprehensive analysis for global BCG Vaccine for Tuberculosis (TB) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for BCG Vaccine for Tuberculosis (TB)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global BCG Vaccine for Tuberculosis (TB) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, BioFarma, GSBPL, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
BCG Vaccine for Tuberculosis (TB) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Type
Therapy Type
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
IVAC – Institute of Vaccines and Medical Biologicals
Institut Pasteur de Tunis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine for Tuberculosis (TB) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Vaccine for Tuberculosis (TB), with price, sales quantity, revenue, and global market share of BCG Vaccine for Tuberculosis (TB) from 2020 to 2025.
Chapter 3, the BCG Vaccine for Tuberculosis (TB) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine for Tuberculosis (TB) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and BCG Vaccine for Tuberculosis (TB) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Tuberculosis (TB).
Chapter 14 and 15, to describe BCG Vaccine for Tuberculosis (TB) sales channel, distributors, customers, research findings and conclusion.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.
A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.
This report is a detailed and comprehensive analysis for global BCG Vaccine for Tuberculosis (TB) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global BCG Vaccine for Tuberculosis (TB) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for BCG Vaccine for Tuberculosis (TB)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global BCG Vaccine for Tuberculosis (TB) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, BioFarma, GSBPL, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
BCG Vaccine for Tuberculosis (TB) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Type
Therapy Type
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
IVAC – Institute of Vaccines and Medical Biologicals
Institut Pasteur de Tunis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine for Tuberculosis (TB) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Vaccine for Tuberculosis (TB), with price, sales quantity, revenue, and global market share of BCG Vaccine for Tuberculosis (TB) from 2020 to 2025.
Chapter 3, the BCG Vaccine for Tuberculosis (TB) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine for Tuberculosis (TB) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and BCG Vaccine for Tuberculosis (TB) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Tuberculosis (TB).
Chapter 14 and 15, to describe BCG Vaccine for Tuberculosis (TB) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
130 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: BCG Vaccine for Tuberculosis (TB) by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
